F. Vergne

Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial

Françis Couturaud, Jeannot Schmidt, Olivier Sanchez et al. · The Lancet · 2025 · 71 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

ALK -rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?

F. Vergne, Gilles Quéré, Sophie Andrieu-Key et al. · Lung Cancer · 2015 · 18 citations

Medicine, Oncology, Pharmacology +14

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues

Arnaud Uguen, Sophie Andrieu-Key, F. Vergne et al. · Oncology Reports · 2016 · 10 citations · Full text

Medicine, Oncology, Pathology +14